Andrews, Laurie |
| Recruiting | 3 | 2000 | US | BCG (Tokyo 172) vaccine, Placebo, sodium glutamate | Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Department of Defense, Uniformed Services University of the Health Sciences | Tuberculosis Infection | 09/27 | 09/27 | | |
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab |
|
|
| Recruiting | N/A | 600 | US | No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment | Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research | HIV Infections, Multi-Antiviral Resistance | 06/25 | 12/25 | | |
Nardell, Edward |
| Recruiting | 3 | 2000 | US | BCG (Tokyo 172) vaccine, Placebo, sodium glutamate | Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Department of Defense, Uniformed Services University of the Health Sciences | Tuberculosis Infection | 09/27 | 09/27 | | |
Wong, Sam |
| Recruiting | 3 | 2000 | US | BCG (Tokyo 172) vaccine, Placebo, sodium glutamate | Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Department of Defense, Uniformed Services University of the Health Sciences | Tuberculosis Infection | 09/27 | 09/27 | | |
| Recruiting | 2 | 350 | Canada, US | Tocilizumab, ACTEMRA, Placebo for Tocilizumab | National Institute of Allergy and Infectious Diseases (NIAID) | Lung Transplant | 01/29 | 01/29 | | |
Kondo, Haley |
| Recruiting | 3 | 2000 | US | BCG (Tokyo 172) vaccine, Placebo, sodium glutamate | Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Department of Defense, Uniformed Services University of the Health Sciences | Tuberculosis Infection | 09/27 | 09/27 | | |